Granules India logo

GRANULES - Granules India Share Price

₹386.95 -2.0  -0.5%

Last Trade - 23/10/20

Mid Cap
Market Cap £994.5m
Enterprise Value £1.06bn
Revenue £300.7m
Position in Universe 239th / 3021
Unlock GRANULES Revenue
Relative Strength (%)
1m +0.19%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.90%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
12,929 13,829 14,353 16,918 22,792 25,986 31,482 36,793 +15.0%
+20.7 +32.1 +27.7 -26.6 +69.6 +35.2 +53.3 +20.5
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 September 2020, Granules India Ltd revenues increased 23% to RS15.94B. Net income increased 54% to RS2.75B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Finance costs decrease of 11% to RS122.2M (expense). Dividend per share remained flat at RS0.50.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for GRANULES
Graphical History


GRANULES Revenue Unlock GRANULES Revenue

Net Income

GRANULES Net Income Unlock GRANULES Revenue

Normalised EPS

GRANULES Normalised EPS Unlock GRANULES Revenue

PE Ratio Range

GRANULES PE Ratio Range Unlock GRANULES Revenue

Dividend Yield Range

GRANULES Dividend Yield Range Unlock GRANULES Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GRANULES EPS Forecasts Unlock GRANULES Revenue
Profile Summary

Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The Company's business operations include three areas: core business, emerging business, and contract research and manufacturing services (CRAMS). Its products in Core business include Paracetamol, Ibuprofen, Guaifenesin and Metformin. The Company operates a healthcare division, Granules Consumer Healthcare (GCH). The Company, through an acquisition, has access to over 10 APIs, as well as intermediates in therapeutic categories, such as anti-histaminic, antihypertensive and anti-convulsants. The Company's PFI products include Compresso PAP 97 S, Compresso PAP 90 CPC and Paracetamol Caffeine Combo 77.4. The Company's FDs include Paracetamol/Acetaminophen, and Acetaminophen and Methocarbamol.

Last Annual March 31st, 2020
Last Interim September 30th, 2020
Incorporated March 18, 1991
Public Since September 20, 1995
No. of Shareholders: 91,283
No. of Employees: 4,843
Sector Healthcare
Industry Pharmaceuticals
Exchange National Stock Exchange of India
Shares in Issue 247,640,796
Free Float (0.0%)
Eligible for
GRANULES Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GRANULES
Upcoming Events for GRANULES
Wednesday 28th October, 2020
Dividend For GRAN.NS - 0.2500 INR
Frequently Asked Questions for Granules India
What is the Granules India share price?

As of 23/10/20, shares in Granules India are trading at ₹386.95, giving the company a market capitalisation of £994.5m. This share price information is delayed by 15 minutes.

How has the Granules India share price performed this year?

Shares in Granules India are currently trading at ₹386.95 and the price has moved by 0.211k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Granules India price has moved by 0.204k% over the past year.

What are the analyst and broker recommendations for Granules India?

Of the analysts with advisory recommendations for Granules India, there are there are currently 4 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Granules India is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Granules India next release its financial results?

Granules India is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-09-30
What is the Granules India dividend yield?

The Granules India dividend yield is 0.26% based on the trailing twelve month period.

Does Granules India pay a dividend?

Last year, Granules India paid a total dividend of 1, and it currently has a trailing dividend yield of 0.26%. Looking ahead, shares in Granules India are due to go ex-dividend on 2020-10-28 and the next dividend pay date is 2020-11-19.

When does Granules India next pay dividends?

Granules India are due to go ex-dividend on 2020-10-28 and the next dividend pay date is 2020-11-19. The historic dividend yield on Granules India shares is currently 0.26%.

How do I buy Granules India shares?

To buy shares in Granules India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Granules India?

Shares in Granules India are currently trading at ₹386.95, giving the company a market capitalisation of £994.5m.

Where are Granules India shares listed? Where are Granules India shares listed?

Here are the trading details for Granules India:

Country of listing: India
Exchange: NSI
Ticker Symbol: GRANULES
What kind of share is Granules India?

Based on an overall assessment of its quality, value and momentum, Granules India is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Granules India share price forecast 2020?

Shares in Granules India are currently priced at ₹386.95. At that level they are trading at 8.21% discount to the analyst consensus target price of 0.00.

Analysts covering Granules India currently have a consensus Earnings Per Share (EPS) forecast of 19.249 for the next financial year.

How can I tell whether the Granules India share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Granules India. Over the past six months, the relative strength of its shares against the market has been 81.88%. At the current price of ₹386.95, shares in Granules India are trading at 68.74% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Granules India PE Ratio?

The Granules India PE ratio based on its reported earnings over the past 12 months is 24.03. The shares are currently trading at ₹386.95.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Granules India?

Granules India's management team is headed by:

Chigurupati Prasad - MDR
Arun Akinepally - NID
Harsha Chigurupati - EDR
Uma Chigurupati - EDR
Kolli Rao - DRC
Chaitanya Tummala - CCO
Arun Sawhney - IND
Robert Cunard - IND
Jyothi Prasad - IND
Sandip Neogi - CFO
Who are the major shareholders of Granules India?

Here are the top five shareholders of Granules India based on the size of their shareholding:

Chigurupati (Krishna Prasad) Individual Investor
Percentage owned: 34.84% (86.3m shares)
Chigurupati (Uma Devi) Individual Investor
Percentage owned: 3.82% (9.46m shares)
Life Insurance Corporation of India Insurance Company
Percentage owned: 3.07% (7.60m shares)
Statens Pensjonsfond Utland Mutual Fund
Percentage owned: 3.04% (7.52m shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 2.99% (7.41m shares)
Similar to GRANULES
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.